Safety Study of SD-101 (a Novel C Type Toll-like Receptor 9 (TLR9) Agonist) for the Treatment of Chronic Hepatitis C Virus (HCV) Infection
Clinical trial NCT00823862 · COMPLETED
Trial details
- NCT number
- NCT00823862
- Sponsor
- Dynavax Technologies Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2009-12-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.